{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:26:08Z","timestamp":1780435568627,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.trre.2021.100675","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:21:21Z","timestamp":1639826481000},"page":"100675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Hefsa Rashed","family":"Al Shamsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2021.100675_bb0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1135-7","article-title":"Recurrent glomerulonephritis following renal transplantation and impact on graft survival","volume":"19","author":"Jiang","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/0886022X.2014.882238","volume":"36","author":"Kienzl-Wagner","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.trre.2021.100675_bb0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jca.21538","article-title":"Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb","volume":"32","author":"Schenk","year":"2017","journal-title":"J Clin Apher"},{"key":"10.1016\/j.trre.2021.100675_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/ijn.IJN_420_17","article-title":"Therapeutic plasma exchange in renal disorders","volume":"29","author":"Ranganathan","year":"2019","journal-title":"Ind J Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0040","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100675_bb0045","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","article-title":"Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome","volume":"20","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","article-title":"Modification of kidney barrier function by the urokinase receptor","volume":"14","author":"Wei","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2021.100675_bb0060","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1097\/01.ASN.0000039569.34360.5E","article-title":"Inherited Podocytopathies: FSGS and Nephrotic syndrome from a genetic viewpoint","volume":"13","author":"Pollak","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40620-019-00660-9","article-title":"Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience","volume":"33","author":"Morello","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0070","author":"[Internet]"},{"key":"10.1016\/j.trre.2021.100675_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0080","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/TP.0000000000002008","article-title":"Rituximab and therapeutic plasma exchange in recurrent focal segmental Glomerulosclerosis Postkidney transplantation","volume":"102","author":"Alasfar","year":"2018","journal-title":"Transplantation."},{"key":"10.1016\/j.trre.2021.100675_bb0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3904\/kjim.2014.29.4.482","article-title":"Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients","volume":"29","author":"Park","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.trre.2021.100675_bb0090","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive Plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0095","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.transproceed.2016.07.001","article-title":"Successful preemptive kidney transplantation with rituximab induction in a patient with focal segmental Glomerulosclerosis and massive Nephrotic syndrome: a case report","volume":"48","author":"Kolonko","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0100","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets Podocytes in recurrent focal segmental Glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trre.2021.100675_bb0105","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/j.1432-2277.2012.01462.x","article-title":"Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation","volume":"25","author":"Audard","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3295618","article-title":"FSGS recurrence in adults after renal transplantation","volume":"2016","author":"Rudnicki","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.trre.2021.100675_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/IJNRD.S126844","article-title":"Optimal management of primary focal segmental glomerulosclerosis in adults","volume":"10","author":"Beaudreuil","year":"2017","journal-title":"Int J Nephrol Renovasc Disease"},{"key":"10.1016\/j.trre.2021.100675_bb0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.10025","article-title":"Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation","volume":"17","author":"Shariatmadar","year":"2002","journal-title":"J Clin Apher"},{"key":"10.1016\/j.trre.2021.100675_bb0125","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1097\/TP.0000000000000914","article-title":"Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor\u2013Mediated Podocyte \u03b23-integrin Activation","volume":"99","author":"Staeck","year":"2015","journal-title":"Transplantation."},{"key":"10.1016\/j.trre.2021.100675_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-1177-x","article-title":"Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab","volume":"19","author":"Alachkar","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0135","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.transproceed.2005.02.061","article-title":"Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental Glomerulosclerosis following renal transplant","volume":"37","author":"Valdivia","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1432-2277.2006.00395.x","article-title":"Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab","volume":"20","author":"Hristea","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0145","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental Glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1432-2277.2004.tb00420.x","article-title":"Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation","volume":"17","author":"Deegens","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0155","first-page":"271","article-title":"Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients","author":"Matalon","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0160","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/TP.0000000000001160","article-title":"Rituximab for recurrence of primary focal segmental Glomerulosclerosis after kidney transplantation","volume":"101","author":"Garrouste","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.trre.2021.100675_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.transproceed.2018.04.078","article-title":"Successful treatment of focal segmental Glomerulosclerosis recurrence in a second kidney transplant patient: a case report","volume":"51","author":"Argiolas","year":"2019","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.trre.2021.100675_bb0170","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-6143.2007.02021.x","article-title":"Rituximab failed to improve Nephrotic syndrome in renal transplant patients with recurrent focal segmental Glomerulosclerosis","volume":"8","author":"Yabu","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5414\/CNP67250","article-title":"Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports","volume":"67","author":"Kamar","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000477944","article-title":"High-dose rituximab ineffective for focal segmental Glomerulosclerosis: a long-term observation study","volume":"46","author":"Roccatello","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0185","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.transproceed.2009.06.044","article-title":"Rituximab and chronic plasmapheresis therapy of Nephrotic syndrome in renal transplantation patients with recurrent focal segmental Glomerulosclerosis","volume":"41","author":"Rodr\u00edguez-Ferrero","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/0886022X.2014.882238","article-title":"Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient","volume":"36","author":"Cho","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.trre.2021.100675_bb0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2006.12.006","article-title":"Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis","volume":"123","author":"Sfikakis","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trre.2021.100675_bb0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrneph.2012.289","article-title":"Rituximab therapy in nephrotic syndrome: implications for patients\u2019 management","volume":"9","author":"Sinha","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-016-0322-7","article-title":"The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: a systematic review and meta-analysis of 77 case-reports and case-series","volume":"17","author":"Kashgary","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0210","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11255-020-02462-6","article-title":"Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis","volume":"52","author":"Hansrivijit","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/gfp538","article-title":"Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation","volume":"25","author":"Ponticelli","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0220","first-page":"1","article-title":"The factors that may predict response to rituximab therapy in recurrent focal segmental Glomerulosclerosis: a systematic review","volume":"2011","author":"Araya","year":"2011","journal-title":"J Transpl"},{"key":"10.1016\/j.trre.2021.100675_bb0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1399-0012.2008.00936.x","article-title":"Reactivation of hepatitis B two years after rituximab therapy in a renal transplant patient with recurrent focal segmental glomerulosclerosis: a note of caution","volume":"23","author":"Gossmann","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0230","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.transproceed.2014.09.010","article-title":"Fatal late-onset pneumocystis pneumonia after rituximab: Administration for Posttransplantation Recurrence of focal segmental Glomerulosclerosis\u2014case report","volume":"46","author":"D\u0119borska-Materkowska","year":"2014","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.trre.2021.100675_bb0235","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/ajt.16504","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: results of a nationwide study","volume":"21","author":"Lanaret","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0240","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of Immunoglobulin levels, infectious risk, and mortality with rituximab and Hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.trre.2021.100675_bb0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000488638","article-title":"Efficacy of the combination of Immunoadsorption and rituximab for treatment in a case of severe focal and segmental Glomerulosclerosis recurrence after renal transplantation","volume":"46","author":"Martin-Moreno","year":"2018","journal-title":"Blood Purif"},{"key":"10.1016\/j.trre.2021.100675_bb0250","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1432-2277.2007.00562.x","article-title":"Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis","volume":"20","author":"Meyer","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0255","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/0886022X.2015.1015366","article-title":"Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience","volume":"37","author":"Lionaki","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.trre.2021.100675_bb0260","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ndt\/gft453","article-title":"Protein a immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis","volume":"29","author":"Beaudreuil","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0265","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/1744-9987.12093","article-title":"Plasmapheresis and Immunoadsorption for treatment and prophylaxis of recurrent focal segmental Glomerulosclerosis in adult recipients of deceased donor renal grafts","volume":"17","author":"Kandus","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.trre.2021.100675_bb0270","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.transproceed.2020.01.024","article-title":"Combination of high-dose intravenous cyclosporine and plasma exchange treatment is effective in post-transplant recurrent focal segmental Glomerulosclerosis: results of case series","volume":"52","author":"Demir","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis De novo","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100675_bb0280","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1432-2277.2004.00054.x","article-title":"Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus","volume":"18","author":"Skhiri","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0285","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1432-2277.2000.tb01059.x","article-title":"Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors","volume":"13","author":"Montagnino","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0290","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1432-2277.2009.00897.x","article-title":"Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"22","author":"Freiberger","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100675_bb0295","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-0012.2005.00399.x","article-title":"Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis - angiotensin II immunostaining and treatment outcome","volume":"19","author":"Mizuiri","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100675_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/ijot.ijot_33_18","article-title":"Recurrent focal segmental glomerulosclerosis after kidney transplant in adults: a report on various treatment regimens","volume":"12","author":"Ramachandran","year":"2018","journal-title":"Ind J Transpl"},{"key":"10.1016\/j.trre.2021.100675_bb0310","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.transproceed.2015.07.013","article-title":"Complete remission of post-transplantation recurrence of focal segmental Glomerulosclerosis with the use of adrenocorticotrophic hormone gel: case report","volume":"47","author":"Mittal","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0315","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.transproceed.2019.04.052","article-title":"Adrenocorticotropic hormone in the treatment of focal segmental glomerulosclerosis following kidney transplantation","volume":"51","author":"Grafals","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100675_bb0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/TP.0000000000002320","article-title":"ACTH gel in resistant focal segmental glomerulosclerosis after kidney transplantation","volume":"103","author":"Alhamad","year":"2019","journal-title":"Transplantation."},{"key":"10.1016\/j.trre.2021.100675_bb0325","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.929097","article-title":"Cyclophosphamide as a treatment for focal segmental glomerular sclerosis recurrence in a kidney transplant patient","volume":"22","author":"Al-Jehani","year":"2021","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.trre.2021.100675_bb0330","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1\u2013positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100675_bb0335","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1681\/ASN.2015091002","article-title":"B7\u20131 blockade does not improve post\u2013transplant nephrotic syndrome caused by recurrent FSGS","volume":"27","author":"Delville","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:07:33Z","timestamp":1760630853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X21000811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0955470X21000811"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2021.100675","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2021.100675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100675"}}